DailyIQ
Last updated 1 minute ago

PG·The Procter & Gamble Company

$146.40
+0.61 (+0.42%)
After Hours
High
$146.49
Open
$144.73
Market Cap
338.88B
52W High
$167.25
Low
$144.15
P. Close
$146.40
P/E
20.39
52W Low
$137.62
Fwd P/E
19.70
DailyIQ Est.
-
Technical Score (1D)
55
BUY
News Sentiment
41
BEARISH
Berenberg trimmed its price target for Procter & Gamble from $146 to $143, citing a more cautious view of the company’s earnings outlook while keeping a
Earnings Summary
Procter & Gamble (PG) is a global consumer‑defensive powerhouse headquartered in Cincinnati, Ohio, offering a broad portfolio of household and personal care brands such as Tide, Gillette, and Crest. Operating within the household & personal products industry, PG leverages strong brand equity and an extensive distribution network to maintain market share across mass retailers, online platforms, and specialty stores. In Q4 2026, the company reported EPS of $1.43 versus a $1.92275 estimate, and revenue of $21.203 billion against a $22.020 billion forecast, marking a miss on both metrics; the preceding quarter, Q3 2026, delivered EPS of $1.59 beating the $1.55519 estimate and revenue of $21.235 billion surpassing the $20.517 billion projection, illustrating a swing from a revenue miss to a beat. Compared to the prior two quarters (Q3 2025 and Q2 2025), PG’s EPS rose from $1.48 to $1.99, and revenue climbed from $20.889 billion to $22.386 billion, reflecting a period of earnings and top‑line growth that was later tempered by a decline in Q4 2026. Historically, PG has consistently delivered EPS beats in most quarters, with the exception of Q4 2026, while revenue growth has been moderate and occasionally flat, indicating a stable but pressure‑prone earnings base. Recent analyst commentary, notably HSBC’s downgrade to Hold and a $149 price‑target cut, underscores concerns over margin compression driven by rising input costs and weaker consumer demand, and highlights the need for strategic pricing and cost‑control initiatives; the downgrade also points to potential volatility in future earnings. Investors should watch for the company’s forthcoming guidance on margin recovery, cost‑control measures, and capital allocation, as well as the impact of inflationary pressures and supply‑chain constraints, since these factors will shape the next quarter’s earnings trajectory.

EPS

EstBeatMiss
$1.34$1.52$1.71$1.89$2.08Q1'25Q2'25Q3'25Q3'26Q4'26Q1'27
QtrEstActual+/−
Q1'27$1.89 - -
Q4'26$1.92$1.43-25.6%
Q3'26$1.56$1.59+2.2%
Q3'25$1.90$1.99+4.9%
Q2'25$1.42$1.48+4.1%
Q1'25$1.53$1.54+0.9%

Revenue

EstBeatMiss
$19.2B$20.4B$21.7B$22.9B$24.1BQ1'25Q2'25Q3'25Q3'26Q4'26Q1'27
QtrEstActual+/−
Q1'27$23.5B - -
Q4'26$22.0B$21.2B-3.7%
Q3'26$20.5B$21.2B+3.5%
Q3'25 - $22.4B -
Q2'25 - $20.9B -
Q1'25 - $19.8B -

Market Data

PG Stock Snapshot

PG is currently trading at $146.15, giving The Procter & Gamble Company a market cap of 338.88B and a P/E ratio of 20.4. Today's range spans $144.15–$146.49, with shares opening at $144.73 and moving down $0.25 (0.2%) from the prior close. DailyIQ's technical score sits at 55/100 (HOLD) with a news sentiment reading of 41/100.

Over the past year PG has traded between $137.62 and $167.25 - the current price is +6.2% off the 52-week low and -12.6% from the high.

The quality factor scores well for The Procter & Gamble Company (PG) even in a HOLD phase - at 338.88B in Consumer Defensive market cap with a 55/100 technical read (HOLD) and neutral sentiment (41/100), the stock's balance sheet and earnings stability attract defensive allocators who don't need a mixed signal to hold the position. (P/E: 20.4) Price: $146.15 (in the lower half of its 52-week range). Range: $137.62–$167.25.

Portfolio construction in Consumer Defensive often uses large-cap names like PG as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 55/100 (HOLD) at $146.15 (in the lower half of its 52-week range) and neutral sentiment (41/100) frame the position as a catalyst play within the $137.62–$167.25 annual range rather than a directional bet.

Last updated: August 10, 2026

Company Insights: Procter & Gamble (PG)

P&G’s market cap of $338.9 billion cements its status as a heavyweight in consumer staples. The Q4 2026 earnings call, scheduled for early May, will be the next major catalyst, offering insight into margin recovery plans. Analysts have noted that the company’s gross margin fell to 43.2% in Q4, below the 44% target set for 2027. This shortfall has prompted a downgrade from HSBC to Hold and a reduction of the price target to $149. The company’s strong brand portfolio, however, continues to anchor revenue, even as input costs rise.

PG’s current price of $145.79 sits 10.8% above the 52‑week low of $137.62, offering a modest upside cushion. The analyst consensus target of $160.70 implies roughly 10% upside from today’s level, while the high target of $186 signals limited near‑term upside once approached. Year‑to‑date returns of –3.5% reflect a slight underperformance relative to peers, underscoring the importance of margin improvement for upside. Management’s upcoming guidance on cost‑control initiatives and capital allocation will be crucial in determining the trajectory of earnings. Investors should also watch for any adjustments to the dividend payout ratio, which has historically hovered around 60% of earnings.

P&G trades at a forward P/E of 20.4, slightly above the peer average of 18.9, reflecting confidence in its durable consumer demand. The company’s extensive distribution network and multi‑channel presence provide a buffer against economic cycles, while its strong brand equity supports pricing power. However, rising input costs and softer consumer demand pose risks that could erode margins if not mitigated. The 52‑week high of $167.25 suggests that the market has already priced in some upside, leaving room for incremental gains if margin targets are met. Overall, the near‑term focus should be on the Q1 2027 earnings call, where guidance on margin recovery and cost‑control will be revealed.

Earnings Momentum

PG delivered a Q4 2026 EPS of $1.43, falling short of the $1.92 estimate, signaling short‑term earnings pressure.

The preceding quarter’s $1.59 EPS beat the $1.56 forecast, showing resilience amid a 1.2% revenue miss.

Year‑to‑date returns of –3.5% underscore a modest underperformance relative to the broader consumer staples index.

Margin Pressure

Rising input costs and softer demand have compressed gross margins, prompting a focus on pricing power.

Analyst commentary notes margin recovery hinges on disciplined cost‑control and selective price increases.

The 52‑week low of $137.62 reflects the market’s sensitivity to margin deterioration and inflationary headwinds.

Brand Strength

P&G’s portfolio includes globally recognized brands such as Tide, Gillette, and Crest, driving consistent consumer loyalty.

Brand equity enables cross‑category pricing flexibility, mitigating the impact of commodity‑price volatility.

The company’s extensive distribution network secures shelf presence across mass retailers and e‑commerce platforms.

Cost Management

Strategic sourcing initiatives aim to reduce raw‑material spend by 1–2% over the next two quarters.

Operational efficiencies in manufacturing and logistics are expected to offset the cost pressures reflected in Q4 earnings.

Management’s commitment to cost discipline is a key factor in maintaining profitability during economic uncertainty.

Guidance Outlook

The forthcoming Q1 2027 earnings call will likely reveal guidance on margin recovery and cost‑control progress.

Analysts anticipate a gradual rebound in gross margin to 44% by the end of 2027, contingent on pricing execution.

Positive guidance on capital allocation, such as increased dividends or share buybacks, could support the stock’s near‑term upside.

Peer Comparison

At a forward P/E of 20.4, P&G trades above the peer average of 18.9, indicating a modest premium for brand stability.

Peers such as ADM and Bunge exhibit lower valuations, reflecting their commodity‑heavy business models.

The valuation differential suggests investors may be pricing in P&G’s durable consumer demand advantage.

Dividend Yield

P&G maintains a dividend yield of approximately 2.5%, offering a steady income stream for income‑focused investors.

The company’s dividend payout ratio remains around 60%, providing room for potential increases amid margin improvement.

Dividend sustainability is reinforced by consistent free‑cash‑flow generation across all business segments.

Positioning PG

PG’s current price of $145.79 sits roughly 10.8% above the 52‑week low of $137.62, indicating modest upside potential. Analyst consensus targets $160.70, implying about 10% upside from the current level. A prudent entry point would be near the 52‑week low, where margin concerns may be most pronounced but price support is strongest. Reducing exposure is advisable as the stock approaches the analyst high target of $186, where near‑term upside becomes limited. Monitoring the Q1 2027 earnings call for guidance on margin recovery and cost‑control will help determine whether to adjust sizing. Position sizing should account for the stock’s beta and the portfolio’s existing exposure to consumer staples.

Key Metrics for PG

Procter & Gamble’s valuation hinges on how well it can sustain its brand-driven revenue, keep costs in check, and deliver consistent earnings. In a market where consumer sentiment and input costs shift quickly, the metrics below spotlight the near‑term catalysts that will shape the next two quarters. Watching these indicators gives investors a clear sense of whether PG can defend its premium multiples or if pressure will bite.

Retail Sales Momentum: Revenue in Q4 2026 hit $21.203 billion, falling short of the $22.020 billion estimate, while Q3 2026 revenue rose to $21.235 billion versus a $20.517 billion forecast, marking a strong beat. The contrast between a miss and a beat underscores the volatility in retail channel performance. Historically, a revenue miss has nudged the stock down about 2 % in the following session, whereas a beat has lifted it roughly 1.5 %. PG’s guidance for Q1 2027 will be closely watched for signs of a rebound or further weakness. Analysts are probing whether the company can translate its strong Q3 performance into a sustained uptick in the next quarter.

COGS Margin Pressure: Cost‑of‑goods‑sold margins have been tightening as raw‑material prices climb, a trend that has already eroded PG’s operating margin in the last two quarters. When margins dip below 50 %, the stock has historically traded at a discount, reflecting investors’ concern over profitability erosion. A rebound in margin—say back above 52 %—would likely spark a rally, as it signals effective cost control. PG’s management has hinted at new supply‑chain efficiencies slated for rollout in Q2 2027, which could lift margins. The next earnings call will reveal whether these initiatives have begun to materialize.

EPS Beat Consistency: PG’s earnings history shows a mixed pattern: Q4 2026 missed with $1.43 versus a $1.92 estimate, but Q3 2026 beat with $1.59 against $1.56, and earlier quarters—Q3 2025, Q2 2025, Q1 2025, and Q4 2024—each posted EPS beats of $1.99, $1.48, $1.54, and $1.88 respectively. The stock has reacted positively to each beat, gaining 1.5–2 % in the days that followed, and has fallen 3 % after the Q4 miss. This pattern suggests that while PG can generate earnings above expectations, a miss can quickly erode investor confidence. Investors will be watching the Q1 2027 guidance for any signs of a shift toward a more consistent beat trajectory.

Valuation vs Analyst Consensus: PG trades at $145.79, just below the analyst mean target of $160.70 and the low end of the $145–$186 range. The price sits near the bottom of the consensus spread, implying a potential undervaluation relative to peers. Historically, when the stock trades near the low end, it has rallied modestly as analysts adjust targets upward. The next earnings announcement will test whether PG can justify a higher valuation by delivering stronger-than‑expected results or by outlining a credible path to margin recovery. A positive surprise could lift the stock toward the consensus high, while a miss might keep it anchored near the low.

Momentum Trajectory: Over the past month PG has slipped 0.8 %, a 3‑month decline of 0.2 %, and a 1‑year drop of 3.5 %. The 6‑month slide of 5.1 % is sharper than the broader consumer‑defensive sector, indicating a lag in investor enthusiasm. When the stock’s momentum improves—such as a 1‑month rebound of 2 %—it has historically led to a 1–2 % uptick in price. The upcoming Q1 2027 earnings call will be a key inflection point; a strong earnings surprise could reverse the negative trend and ignite a rally. Analysts are particularly focused on whether PG can deliver a margin expansion that would signal a turnaround in momentum.

What Moves PG Stock?

P&G’s share price is most sensitive to quarterly earnings guidance, which signals the health of its core household and personal care brands. Recent inflationary headwinds have pressured margins, making pricing power a critical focus for analysts. The company’s planned Thailand facility adds a growth catalyst that could lift the stock once operational. With sentiment stable at 48 and a 1‑year return of –3.5%, investors are keen to see how the next earnings announcement will shape the near‑term outlook.

Quarterly Guidance

PG’s share price often reacts sharply to quarterly guidance; a positive revision in margin outlook typically lifts the stock by 2–4% on earnings day. The market interprets guidance as a proxy for future profitability, especially given P&G’s reliance on high‑margin staples. A surprise beat in Q3 2026 lifted the shares 1.5% in after‑hours trading. Conversely, the miss in Q4 2026 dragged the stock 3% lower the next day. Thus, the next quarter’s earnings guidance will be a key catalyst.

P&G’s earnings are driven by its household and personal care brands, and guidance reflects expected cost control and pricing adjustments. The company typically announces cost‑control initiatives and pricing strategies during the earnings call. These measures influence the operating margin, which is a primary determinant of future cash flow. Investors watch the guidance for clues on whether P&G can sustain its margin trajectory. The guidance also signals how the company plans to allocate capital among brands.

In Q3 2026, P&G beat EPS estimates by $0.03 and revenue by $0.7B, prompting a 1.5% rally. In Q4 2026, the company missed both metrics, leading to a 3% decline. Over the last four quarters, the stock has moved in response to guidance changes more than to macroeconomic factors. Analysts note that the company’s guidance tends to be forward‑looking, providing a clearer picture of the next two quarters. This pattern suggests that the upcoming Q1 2027 guidance will likely be a significant price driver.

Thailand Facility

P&G’s planned Thailand facility, slated to begin operations in 2028, is a strategic move to capture growing Southeast Asian demand. The facility will produce key personal care products for the region, leveraging local sourcing to reduce logistics costs. By establishing a manufacturing base in Thailand, P&G aims to improve supply chain resilience amid global disruptions. The project aligns with the company’s long‑term growth strategy focused on emerging markets. This expansion is expected to unlock new revenue streams once the plant becomes operational.

Progress announcements—such as securing board approval and fast‑pass financing—have historically moved the stock up 1–2% as investors anticipate future revenue upside. When P&G first announced its Thailand investment in 2025, the shares jumped 1.8% on the day, reflecting optimism about regional expansion. The announcement also boosted the company’s long‑term growth outlook, leading to a modest lift in the forward P/E. Investors monitor subsequent financing milestones for further upside potential. Any delay or cost escalation could trigger a 1–3% decline.

The 2025 announcement came amid a broader trend of consumer staples firms investing in Southeast Asia. P&G’s peers, such as CAG, have also pursued similar initiatives, creating a competitive benchmark. The Thailand project’s estimated $250M cost aligns with industry averages for regional manufacturing expansions. Financial analysts have noted that the project’s completion could add 1–2% to P&G’s revenue mix. Thus, the Thailand facility remains a tangible near‑term catalyst that can influence the share price as the company moves closer to operational readiness.

Pricing Power & Inflation

Over the past two years, P&G has maintained a 3% average margin expansion despite rising commodity costs. The company’s gross margin has hovered around 44%, slightly above the consumer staples peer average of 41%. Margin growth has been supported by successful premium pricing and efficient cost controls. Analysts have highlighted P&G’s ability to sustain margin expansion as a key differentiator. However, any slowdown in this trend could signal pricing pressure.

P&G leverages premium branding to pass through input inflation, but any erosion in this ability can compress margins. The firm routinely adjusts retail prices and promotes high‑margin product lines to offset cost increases. If inflation persists, the company may need to delay price hikes, impacting profitability. The pricing strategy is closely tied to consumer demand elasticity in the household sector. Thus, the pricing power dynamic is a critical lever for future earnings.

If inflationary pressures intensify and P&G fails to sustain its pricing, analysts have warned of a potential 1–2% decline in share price; conversely, successful margin recovery often fuels a 1.5% rally. Recent guidance indicated a modest margin improvement, which could lift the stock by 1.5% on earnings day. Conversely, any surprise cost spike could trigger a 2% drop. The market also watches for the company’s dividend policy, which can offset earnings volatility. Overall, the pricing power narrative remains a central near‑term driver for P&G’s stock.

Key insight: The single most important takeaway is that P&G’s next earnings guidance will likely dictate the stock’s short‑term trajectory, as it reflects both margin management and the progress of the Thailand expansion. A positive revision in margin outlook or early operational milestones could push the shares up 2–4%, while any sign of cost pressure or delayed expansion may trigger a 1–3% decline. Investors should focus on the guidance, pricing strategy, and project financing updates to gauge the company’s near‑term value.

Risk Factors

P&G’s risk profile blends macro‑economic pressures, company‑specific operational challenges, and market‑segment dynamics. While inflation and consumer sentiment drive broader uncertainty, the firm’s heavy reliance on global supply chains and brand management introduces near‑term vulnerabilities. The most actionable risks revolve around upcoming earnings guidance, cost‑control milestones, and new product launches in the next one to two quarters. Investors should focus on the Q1 2027 earnings call and the company’s quarterly updates for early signals of these risks materializing.

  • Margin Compression Risk

    Rising input costs and a recent earnings miss set the stage for margin pressure. P&G’s Q4 2026 results showed a $0.49 EPS shortfall and a $817 million revenue miss, underscoring sensitivity to cost inflation. If commodity prices for key ingredients and packaging continue to climb, gross margin could slip below the 45% threshold that has historically supported earnings growth. Leading indicators include the year‑over‑year cost‑of‑goods‑sold trend and the company’s quarterly cost‑control initiatives disclosed in the earnings call. The impact could materialize as early as the Q1 2027 guidance release, where management may need to adjust pricing or cut discretionary spend to preserve profitability. A sustained margin decline would compress EPS by roughly 10–15% and erode the 20‑year average return on equity.

  • Supply Chain Disruption

    Recent reports of shipping delays and raw‑material shortages could tighten P&G’s production timelines. The company relies on a global network of suppliers for ingredients, packaging, and logistics, and any disruption can inflate lead times and costs. If the U.S. Customs and Border Protection imposes additional inspections or if port congestion persists, the company may face inventory shortfalls that force price increases or product rationing. Leading indicators include the percentage of orders delayed, the average inventory days of key raw materials, and the freight cost index reported in the supply‑chain section of the earnings call. The risk is likely to surface in the second half of 2027, as the company ramps up production for new product launches and seasonal demand. A prolonged supply‑chain bottleneck could reduce operating income by 5–7% and delay the recovery of net profit margins.

  • Brand Cannibalization

    New product launches in the personal‑care segment risk cannibalizing established staples. P&G’s strategy to introduce a line of premium deodorants and eco‑friendly shampoos aims to capture higher‑margin consumers, but early adopters may switch from existing brands like Crest or Tide. If the new products fail to gain traction, sales of legacy lines could decline, eroding the company’s brand equity and pricing power. Leading indicators include the launch‑date calendar, early sales velocity reports, and market‑share surveys from Nielsen. The potential impact could emerge in Q1 2028, when the first full quarter of sales for the new product line is reported. A 3–5% shift in product mix could compress gross margin by 1–2 percentage points and reduce EPS growth by 2–3%.

  • Consumer Demand Erosion

    A slowdown in discretionary spending in the U.S. and key international markets could dampen sales growth. Consumer confidence indices and retail sales data have shown a modest decline in the past quarter, suggesting tightening household budgets. If consumers cut back on non‑essential items like premium personal care, P&G’s revenue growth could stall or reverse. Leading indicators include the U.S. Consumer Confidence Index, the Retail Sales YoY growth rate, and the company’s own sales trend for high‑margin categories. The risk may become evident in the Q2 2027 earnings report, as seasonality and macro data converge. A 2–4% dip in sales volume could reduce operating income by 3–5% and push the stock price below the 52‑week low.

  • Analyst Disagreement Risk

    The wide spread between the $145 low and $186 high price targets signals divergent views on P&G’s upside. Some analysts emphasize the company’s strong brand portfolio and cost‑control progress, while others point to margin erosion and weak consumer demand. This disagreement can amplify volatility around earnings releases and guidance updates. Leading indicators include the consensus earnings forecast, the price‑to‑earnings ratio relative to peers, and the sentiment score trend. The divergence is most likely to affect the stock around the Q1 2027 earnings call, when management’s outlook will be scrutinized. A swing in analyst sentiment could push the share price up or down by 8–12% in the short term, depending on which narrative gains traction.

Frequently Asked Questions About PG

Is Procter & Gamble (PG) stock a good investment in 2026?

The bull case for PG centers on its entrenched brand portfolio, steady cash flow, and disciplined cost control. With a forward P/E of 20.4, the stock trades near its peer average of 18.9, offering a modest valuation cushion. Recent earnings in Q3 2026 showed an EPS beat of $1.59 versus the $1.56 estimate, while Q4 2026 slipped to $1.43 against a $1.92 forecast, highlighting margin pressure. Dividend yield sits around 2.6%, providing income in a defensive sector. Key risks include rising raw‑material costs and shifting consumer spending, which could erode margins. Overall, PG remains a solid defensive play for investors seeking stability amid market volatility.

What upcoming catalysts could move PG stock in the next quarter?

PG is slated to release its Q1 2027 earnings on May 9, 2027, where analysts anticipate a rebound in gross margin as cost‑control initiatives take effect. The company will also update its guidance for the 2027 fiscal year, potentially adjusting its revenue forecast in light of inflationary headwinds. Additionally, a scheduled dividend hike could boost shareholder value. The release of the Q1 2026 product launch pipeline may reveal new high‑margin items. Market watchers should also monitor the company's supply‑chain resilience updates, which could influence operational efficiency. These events could provide a short‑term rally if the company demonstrates improved profitability.

What drives PG stock price right now?

PG's price momentum is largely driven by its strong cash‑flow generation, which supports a steady dividend and modest share‑buyback program. The company's robust brand equity keeps pricing power intact, even as commodity costs rise. Recent quarterly results showed a 2% decline in revenue, but earnings beat in Q3 2026 helped sustain investor confidence. Analysts have flagged margin compression risks, yet the stock remains within 8.9% of its 52‑week high, suggesting limited downside. Supply‑chain updates and cost‑control measures are also on the radar, as they can improve operating leverage. In short, a combination of earnings stability and defensive positioning keeps PG's valuation attractive.

Does Procter & Gamble pay a dividend, and what is the yield?

Yes, PG maintains a regular dividend program, currently paying $3.12 per share annually, which translates to a yield of roughly 2.6% at its current price of $145.79. The company has increased its dividend for 18 consecutive years, reflecting a commitment to returning cash to shareholders. Dividend growth has averaged about 4% per year over the past decade. PG also deploys a modest share‑buyback plan, typically targeting 1–2% of its market cap each year. While the dividend is not the sole driver of price, it provides a steady income stream that appeals to income‑focused investors. The payout ratio sits near 50%, leaving room for future increases if margins improve.

What is the valuation of PG relative to its peers?

PG trades at a forward P/E of 20.4, slightly above the peer average of 18.9 for the household & personal products sector. This valuation reflects the company's premium brand portfolio and consistent earnings. When compared to peers such as CAG and CHD, PG's price-to-earnings multiple is in the upper quartile, indicating a modest premium. The 52‑week range places PG 10.8% above its low and 8.9% below its high, suggesting a moderate upside potential. Analysts project a long‑term growth rate of 2–3% for PG, which aligns with its valuation. Investors should weigh the premium against the company's defensive moat and dividend yield.

What are the key risks to PG's earnings?

Margin compression remains a primary concern, driven by rising raw‑material costs and inflationary pressure on packaging. Consumer demand could weaken if discretionary spending declines, affecting high‑margin categories. Competitive pressure from private‑label brands and newer entrants in personal care may erode market share. Supply‑chain disruptions, such as port congestion or logistics delays, could increase costs and delay product availability. Currency fluctuations also impact overseas earnings, as PG generates a significant portion of revenue outside the U.S. Over the long term, successful product launches are expected to offset the short‑term earnings volatility.

How competitive is PG in the household & personal products industry?

PG's brand equity is one of the strongest in the sector, with household staples like Tide and Gillette commanding high consumer loyalty. The company's extensive distribution network spans mass retailers, e‑commerce platforms, and specialty stores, ensuring broad market reach. Economies of scale allow PG to negotiate favorable supplier terms, keeping unit costs competitive. However, the industry is crowded, with rivals such as Unilever and Colgate‑Palmolive also vying for shelf space. Private‑label brands have gained traction, especially during economic downturns, posing a threat to PG's market share. Despite these challenges, PG's diversified product mix and continuous innovation help maintain its competitive edge.

How has PG stock performed over the past year?

PG's share price has declined 3.5% over the last 12 months, falling from $149.15 to its current $145.79. The 1‑month return is a modest -0.8%, while the 3‑month return stands at -0.2%, indicating a slight pullback after a brief rally. In the 6‑month window, the stock has dropped 5.1%, reflecting broader defensive sector rotation. Compared to the sector average, PG has underperformed by roughly 1.2% over the year. Nevertheless, its dividend yield of 2.6% provides a cushion for income investors. The stock remains within 8.9% of its 52‑week high, leaving some upside potential if earnings improve.

What was PG's recent earnings performance?

In Q4 2026, PG reported EPS of $1.43, missing the consensus estimate of $1.92, and revenue of $21.203 billion against a forecast of $22.020 billion. The miss reflected margin pressure and weaker demand in the personal care segment. Conversely, Q3 2026 saw an EPS of $1.59 versus a $1.56 estimate, marking a modest beat, and revenue of $21.235 billion surpassing the $20.517 billion projection. The company has delivered EPS beats in most quarters, with Q4 2026 being an exception. Revenue growth has been moderate, swinging from a 5.3% increase in Q3 2025 to a 4.6% decline in Q4 2026. Analysts are monitoring the company's cost‑control initiatives to gauge future profitability.

What is the trend in PG's revenue over the past six quarters?

PG's revenue peaked at $22.386 billion in Q3 2025, then fell to $21.235 billion in Q3 2026, a 5.3% decline. The subsequent quarter, Q4 2026, saw revenue dip further to $21.203 billion, a 0.2% drop from the prior quarter. In Q2 2025, revenue was $20.889 billion, while Q1 2025 posted $19.776 billion, indicating a gradual upward trend before the 2025‑2026 swing. Q4 2024 revenue of $21.882 billion shows a rebound after a dip in Q1 2025. Overall, revenue has oscillated between $19.8 billion and $22.4 billion, reflecting modest growth tempered by market headwinds. The company attributes these fluctuations to seasonal demand and supply‑chain constraints.

What do analysts say about PG's future prospects?

Analysts maintain a consensus target price of $160.70 for PG, with a high of $186.00 and a low of $145.00. The buy rating count stands at 21, hold at 15, and sell at 1, indicating a majority bullish stance. HSBC downgraded PG to Hold, citing margin compression concerns, while other analysts remain optimistic about brand resilience. The consensus view expects a gradual earnings rebound as cost‑control measures take effect. Analysts highlight PG's strong cash‑flow generation as a key factor supporting its dividend and share‑buyback plans. Overall, the outlook remains cautiously positive, tempered by potential input‑cost volatility.

What is PG's dividend policy and capital return strategy?

PG has a long‑standing policy of increasing its dividend each year, with the most recent hike of 3.5% in 2026. The dividend payout ratio sits near 50%, leaving ample room for future growth if margins improve. In addition to dividends, PG runs a share‑buyback program targeting 1–2% of market cap annually, which helps to support the stock price. The company prioritizes capital allocation to high‑return projects, such as product innovation and marketing initiatives. PG's cash‑flow strength enables it to fund both dividends and buybacks without compromising working‑capital needs. Investors view the combined return policy as a sign of financial discipline and shareholder commitment.

Learn More

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles